TermID Term Enrichment logP Genes in Term Target Genes in Term Fraction of Targets in Term Total Target Genes Total Genes Entrez Gene IDs Gene Symbols WP364 IL-6 signaling pathway 8.7697985115761e-05 -9.34161163358483 43 4 0.133333333333333 30 5310 5580,2549,3570,3055 PRKCD,GAB1,IL6R,HCK WP23 B Cell Receptor Signaling Pathway 0.000191005541285091 -8.56320811837466 98 5 0.166666666666667 30 5310 2549,5580,5777,5336,29760 GAB1,PRKCD,PTPN6,PLCG2,BLNK WP69 T-Cell antigen Receptor (TCR) Signaling Pathway 0.00157318266180524 -6.45465453844037 91 4 0.133333333333333 30 5310 8631,5580,10451,2533 SKAP1,PRKCD,VAV3,FYB1 WP80 Nucleotide GPCRs 0.00164445324906089 -6.41034732140397 11 2 0.0666666666666667 30 5310 5029,5031 P2RY2,P2RY6 WP185 Integrin-mediated Cell Adhesion 0.00248281832166259 -5.99836094401645 103 4 0.133333333333333 30 5310 7094,10451,9815,1793 TLN1,VAV3,GIT2,DOCK1 WP1584 Type II diabetes mellitus 0.00664527283255646 -5.01384952933678 22 2 0.0666666666666667 30 5310 23533,5580 PIK3R5,PRKCD WP2261 Signaling Pathways in Glioblastoma 0.0110316657245151 -4.50698543948365 83 3 0.1 30 5310 5580,5336,2549 PRKCD,PLCG2,GAB1 WP289 Myometrial Relaxation and Contraction Pathways 0.0113146080856973 -4.48166063720023 158 4 0.133333333333333 30 5310 113,5336,5580,10636 ADCY7,PLCG2,PRKCD,RGS14 WP313 Signaling of Hepatocyte Growth Factor Receptor 0.0154756187840346 -4.16848947516666 34 2 0.0666666666666667 30 5310 2549,1793 GAB1,DOCK1 WP35 G Protein Signaling Pathways 0.0158810997734964 -4.14262557030322 95 3 0.1 30 5310 113,11214,5580 ADCY7,AKAP13,PRKCD WP244 Alpha 6 Beta 4 signaling pathway 0.0163563840184848 -4.11313699800232 35 2 0.0666666666666667 30 5310 2549,5580 GAB1,PRKCD WP619 Type II interferon signaling (IFNG) 0.0181809414305474 -4.00738140771505 37 2 0.0666666666666667 30 5310 6688,5580 SPI1,PRKCD WP306 Focal Adhesion 0.0228826902209622 -3.77737453979497 195 4 0.133333333333333 30 5310 3055,7094,1793,23533 HCK,TLN1,DOCK1,PIK3R5 WP2203 Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway 0.0285007552001696 -3.55782469380704 47 2 0.0666666666666667 30 5310 6778,3055 STAT6,HCK WP2848 Differentiation Pathway 0.029636802945611 -3.5187383472055 48 2 0.0666666666666667 30 5310 1436,3570 CSF1R,IL6R WP286 IL-3 Signaling Pathway 0.0307908481964654 -3.48053776963479 49 2 0.0666666666666667 30 5310 5777,3055 PTPN6,HCK WP3646 Hepatitis C and Hepatocellular Carcinoma 0.0331520334547286 -3.40665122321409 51 2 0.0666666666666667 30 5310 3091,3570 HIF1A,IL6R WP2864 Apoptosis-related network due to altered Notch3 in ovarian cancer 0.0368232290784671 -3.30162640798758 54 2 0.0666666666666667 30 5310 348,10451 APOE,VAV3 WP673 ErbB Signaling Pathway 0.0368232290784671 -3.30162640798758 54 2 0.0666666666666667 30 5310 23533,2549 PIK3R5,GAB1 WP395 IL-4 Signaling Pathway 0.0380805997553601 -3.26805031930485 55 2 0.0666666666666667 30 5310 6778,5777 STAT6,PTPN6 WP1449 Regulation of toll-like receptor signaling pathway 0.0472962752462287 -3.05132373402202 145 3 0.1 30 5310 23533,5777,3663 PIK3R5,PTPN6,IRF5 WP3593 miR-148a/miR-31/FIH1/HIF1α-Notch signaling in glioblastoma 0.049750027352532 -3.00074426557805 9 1 0.0333333333333333 30 5310 3091 HIF1A WP536 Calcium Regulation in the Cardiac Cell 0.0522689193013216 -2.95135336178534 151 3 0.1 30 5310 5580,113,10636 PRKCD,ADCY7,RGS14 WP2374 Oncostatin M Signaling Pathway 0.0529522159178928 -2.93836535855839 66 2 0.0666666666666667 30 5310 5580,3091 PRKCD,HIF1A WP2324 AGE/RAGE pathway 0.0529522159178928 -2.93836535855839 66 2 0.0666666666666667 30 5310 3091,5580 HIF1A,PRKCD WP3601 Composition of Lipid Particles 0.0551277861106196 -2.89810140480307 10 1 0.0333333333333333 30 5310 348 APOE WP3630 NAD metabolism, sirtuins and aging 0.060476119397764 -2.80550671256618 11 1 0.0333333333333333 30 5310 3091 HIF1A WP481 Insulin Signaling 0.0611037791232386 -2.79518156327314 161 3 0.1 30 5310 115703,2549,5580 ARHGAP33,GAB1,PRKCD WP437 EGF/EGFR Signaling Pathway 0.0620241862750004 -2.78023086879706 162 3 0.1 30 5310 5580,10451,2549 PRKCD,VAV3,GAB1 WP3672 LncRNA-mediated mechanisms of therapeutic resistance 0.0657951826958844 -2.72120865463969 12 1 0.0333333333333333 30 5310 3091 HIF1A WP3892 Development of pulmonary dendritic cells and macrophage subsets 0.0710851306978941 -2.64387709628191 13 1 0.0333333333333333 30 5310 6688 SPI1 WP3644 NAD+ metabolism 0.086781818053235 -2.44435814869039 16 1 0.0333333333333333 30 5310 203447 NRK WP2355 Corticotropin-releasing hormone signaling pathway 0.0962528680093509 -2.34077650875843 93 2 0.0666666666666667 30 5310 5336,5580 PLCG2,PRKCD WP75 Toll-like Receptor Signaling Pathway 0.114224406656146 -2.1695902860646 103 2 0.0666666666666667 30 5310 23533,3663 PIK3R5,IRF5 WP167 Eicosanoid Synthesis 0.117409611392442 -2.14208650617905 22 1 0.0333333333333333 30 5310 6916 TBXAS1 WP615 Senescence and Autophagy in Cancer 0.119779053320885 -2.1221064556594 106 2 0.0666666666666667 30 5310 3663,3570 IRF5,IL6R WP1539 Angiogenesis 0.127396409621527 -2.06045171817583 24 1 0.0333333333333333 30 5310 3091 HIF1A WP2643 Nanoparticle-mediated activation of receptor signaling 0.151887835738318 -1.88461295330911 29 1 0.0333333333333333 30 5310 7094 TLN1 WP2583 T-Cell Receptor and Co-stimulatory Signaling 0.151887835738318 -1.88461295330911 29 1 0.0333333333333333 30 5310 5777 PTPN6 WP98 Prostaglandin Synthesis and Regulation 0.156705742371602 -1.85338548465278 30 1 0.0333333333333333 30 5310 6916 TBXAS1 WP2870 Extracellular vesicle-mediated signaling in recipient cells 0.156705742371602 -1.85338548465278 30 1 0.0333333333333333 30 5310 23533 PIK3R5 WP236 Adipogenesis 0.168395162513573 -1.78144190375294 131 2 0.0666666666666667 30 5310 3091,6778 HIF1A,STAT6 WP3676 BDNF-TrkB Signaling 0.171001251049467 -1.76608440642749 33 1 0.0333333333333333 30 5310 2549 GAB1 WP430 Statin Pathway 0.171001251049467 -1.76608440642749 33 1 0.0333333333333333 30 5310 348 APOE WP2012 miRs in Muscle Cell Differentiation 0.185062367816246 -1.68706238738605 36 1 0.0333333333333333 30 5310 5580 PRKCD WP3298 Melatonin metabolism and effects 0.185062367816246 -1.68706238738605 36 1 0.0333333333333333 30 5310 348 APOE WP3614 Photodynamic therapy-induced HIF-1 survival signaling 0.189697962995833 -1.66232214012817 37 1 0.0333333333333333 30 5310 3091 HIF1A WP2380 Brain-Derived Neurotrophic Factor (BDNF) signaling pathway 0.194909336213043 -1.63522077103488 144 2 0.0666666666666667 30 5310 5580,10451 PRKCD,VAV3 WP51 Regulation of Actin Cytoskeleton 0.205261643765431 -1.58346980258543 149 2 0.0666666666666667 30 5310 1793,23533 DOCK1,PIK3R5 WP706 Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways 0.232464278603834 -1.45901870617224 162 2 0.0666666666666667 30 5310 3091,3570 HIF1A,IL6R WP2849 Hematopoietic Stem Cell Differentiation 0.239036323964248 -1.43113975548488 48 1 0.0333333333333333 30 5310 6688 SPI1 WP1533 Vitamin B12 Metabolism 0.260490684282758 -1.34518817933887 53 1 0.0333333333333333 30 5310 348 APOE WP585 Interferon type I signaling pathways 0.268907680965578 -1.31338715172116 55 1 0.0333333333333333 30 5310 5777 PTPN6 WP2018 RANKL/RANK (Receptor activator of NFKB (ligand)) Signaling Pathway 0.268907680965578 -1.31338715172116 55 1 0.0333333333333333 30 5310 6688 SPI1 WP304 Kit receptor signaling pathway 0.289547011526009 -1.23943760646183 60 1 0.0333333333333333 30 5310 5777 PTPN6 WP61 Notch Signaling Pathway 0.297644044800013 -1.21185698697408 62 1 0.0333333333333333 30 5310 3091 HIF1A WP3863 T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection 0.297644044800013 -1.21185698697408 62 1 0.0333333333333333 30 5310 5777 PTPN6 WP428 Wnt Signaling Pathway 0.329149231444316 -1.11124404004192 70 1 0.0333333333333333 30 5310 5580 PRKCD WP2572 Primary Focal Segmental Glomerulosclerosis FSGS 0.344385119498157 -1.06599471439408 74 1 0.0333333333333333 30 5310 7094 TLN1 WP2034 Leptin signaling pathway 0.351877086032227 -1.0444733517726 76 1 0.0333333333333333 30 5310 5336 PLCG2 WP2037 Prolactin Signaling Pathway 0.351877086032227 -1.0444733517726 76 1 0.0333333333333333 30 5310 5777 PTPN6 WP254 Apoptosis 0.388112585707049 -0.946459812101782 86 1 0.0333333333333333 30 5310 3663 IRF5 WP455 GPCRs, Class A Rhodopsin-like 0.434131024575618 -0.83440889050053 259 2 0.0666666666666667 30 5310 5031,5029 P2RY6,P2RY2 WP179 Cell Cycle 0.451639733399248 -0.794870466964809 105 1 0.0333333333333333 30 5310 11138 TBC1D8 WP399 Wnt Signaling Pathway and Pluripotency 0.454800311308693 -0.787896832610183 106 1 0.0333333333333333 30 5310 5580 PRKCD WP710 DNA Damage Response (only ATM dependent) 0.479458775602543 -0.73509736207192 114 1 0.0333333333333333 30 5310 23533 PIK3R5 WP2858 Ectoderm Differentiation 0.560124409457052 -0.579596360182029 143 1 0.0333333333333333 30 5310 55843 ARHGAP15 WP2853 Endoderm Differentiation 0.56521797565102 -0.570543824624036 145 1 0.0333333333333333 30 5310 10451 VAV3 WP2059 Alzheimers Disease 0.572751573118702 -0.557303211046102 148 1 0.0333333333333333 30 5310 348 APOE WP2857 Mesodermal Commitment Pathway 0.58984248991885 -0.527899743963439 155 1 0.0333333333333333 30 5310 10451 VAV3 WP382 MAPK Signaling Pathway 0.624269205530708 -0.471173584527457 170 1 0.0333333333333333 30 5310 5580 PRKCD WP2359 Parkin-Ubiquitin Proteasomal System pathway 0.999999999987514 -1.24860846043005e-11 70 0 0 30 5310 WP2447 Amyotrophic lateral sclerosis (ALS) 0.99999999999162 -8.38009754253992e-12 38 0 0 30 5310 WP383 Striated Muscle Contraction 0.99999999999162 -8.38009754253992e-12 38 0 0 30 5310 WP2526 PDGF Pathway 0.99999999999162 -8.38009754253992e-12 38 0 0 30 5310 WP2029 Cell Differentiation - Index 0.99999999999162 -8.38009754253992e-12 38 0 0 30 5310 WP3679 Cell-type Dependent Selectivity of CCK2R Signaling 0.999999999992752 -7.24830101777982e-12 13 0 0 30 5310 WP1434 Osteopontin Signaling 0.999999999992752 -7.24830101777982e-12 13 0 0 30 5310 WP2881 Estrogen Receptor Pathway 0.999999999992752 -7.24830101777982e-12 13 0 0 30 5310 WP1423 Ganglio Sphingolipid Metabolism 0.999999999992752 -7.24830101777982e-12 13 0 0 30 5310 WP3876 BMP2-WNT4-FOXO1 Pathway in Human Primary Endometrial Stromal Cell Differentiation 0.999999999992752 -7.24830101777982e-12 13 0 0 30 5310 WP3871 Valproic acid pathway 0.999999999992752 -7.24830101777982e-12 13 0 0 30 5310 WP186 Homologous recombination 0.999999999992752 -7.24830101777982e-12 13 0 0 30 5310 WP1991 SRF and miRs in Smooth Muscle Differentiation and Proliferation 0.999999999992752 -7.24830101777982e-12 13 0 0 30 5310 WP2369 Histone Modifications 0.999999999995002 -4.99756413159982e-12 69 0 0 30 5310 WP176 Folate Metabolism 0.999999999995002 -4.99756413159982e-12 69 0 0 30 5310 WP707 DNA Damage Response 0.999999999995002 -4.99756413159982e-12 69 0 0 30 5310 WP2795 Cardiac Hypertrophic Response 0.999999999995332 -4.66851229485875e-12 57 0 0 30 5310 WP195 IL-1 signaling pathway 0.999999999995332 -4.66851229485875e-12 57 0 0 30 5310 WP697 Estrogen metabolism 0.99999999999554 -4.46019309412657e-12 19 0 0 30 5310 WP22 IL-9 Signaling Pathway 0.99999999999554 -4.46019309412657e-12 19 0 0 30 5310 WP2011 SREBF and miR33 in cholesterol and lipid homeostasis 0.99999999999554 -4.46019309412657e-12 19 0 0 30 5310 WP734 Serotonin Receptor 4/6/7 and NR3C Signaling 0.99999999999554 -4.46019309412657e-12 19 0 0 30 5310 WP247 Small Ligand GPCRs 0.99999999999554 -4.46019309412657e-12 19 0 0 30 5310 WP2879 Farnesoid X Receptor Pathway 0.99999999999554 -4.46019309412657e-12 19 0 0 30 5310 WP404 Nucleotide Metabolism 0.99999999999554 -4.46019309412657e-12 19 0 0 30 5310 WP384 Apoptosis Modulation by HSP70 0.99999999999554 -4.46019309412657e-12 19 0 0 30 5310 WP3287 Overview of nanoparticle effects 0.99999999999554 -4.46019309412657e-12 19 0 0 30 5310 WP1992 TarBasePathway 0.99999999999554 -4.46019309412657e-12 19 0 0 30 5310 WP3877 Simplified Depiction of MYD88 Distinct Input-Output Pathway 0.99999999999554 -4.46019309412657e-12 19 0 0 30 5310 WP2942 DDX1 as a regulatory component of the Drosha microprocessor 0.99999999999556 -4.43970589938126e-12 9 0 0 30 5310 WP696 Benzo(a)pyrene metabolism 0.99999999999556 -4.43970589938126e-12 9 0 0 30 5310 WP3585 Cytosine methylation 0.99999999999556 -4.43970589938126e-12 9 0 0 30 5310 WP3297 EV release from cardiac cells and their functional effects 0.99999999999556 -4.43970589938126e-12 9 0 0 30 5310 WP3875 ATR Signaling 0.99999999999556 -4.43970589938126e-12 9 0 0 30 5310 WP3300 Dual hijack model of Vif in HIV infection 0.99999999999556 -4.43970589938126e-12 9 0 0 30 5310 WP3674 Tgif disruption of Shh signaling 0.99999999999556 -4.43970589938126e-12 9 0 0 30 5310 WP531 Mismatch repair 0.99999999999556 -4.43970589938126e-12 9 0 0 30 5310 WP561 Heme Biosynthesis 0.99999999999556 -4.43970589938126e-12 9 0 0 30 5310 WP288 NLR Proteins 0.99999999999556 -4.43970589938126e-12 9 0 0 30 5310 WP2272 Pathogenic Escherichia coli infection 0.999999999997115 -2.88459328615763e-12 55 0 0 30 5310 WP560 TGF-beta Receptor Signaling 0.999999999997492 -2.50788958019432e-12 58 0 0 30 5310 WP334 GPCRs, Class B Secretin-like 0.999999999997502 -2.49809148199963e-12 24 0 0 30 5310 WP3658 Wnt/beta-catenin Signaling Pathway in Leukemia 0.999999999997502 -2.49809148199963e-12 24 0 0 30 5310 WP2509 Nanoparticle triggered autophagic cell death 0.999999999997502 -2.49809148199963e-12 24 0 0 30 5310 WP262 EBV LMP1 signaling 0.999999999997502 -2.49809148199963e-12 24 0 0 30 5310 WP500 Glycogen Metabolism 0.999999999998023 -1.97669897802064e-12 36 0 0 30 5310 WP314 Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation 0.999999999998028 -1.97230729523382e-12 44 0 0 30 5310 WP2332 Interleukin-11 Signaling Pathway 0.999999999998028 -1.97230729523382e-12 44 0 0 30 5310 WP716 Vitamin A and Carotenoid Metabolism 0.999999999998028 -1.97230729523382e-12 44 0 0 30 5310 WP2846 Proprotein convertase subtilisin/kexin type 9 (PCSK9) mediated LDL receptor degradation 0.999999999998492 -1.50825372061061e-12 3 0 0 30 5310 WP3408 Evolocumab Mechanism 0.999999999998492 -1.50825372061061e-12 3 0 0 30 5310 WP1545 miRNAs involved in DNA damage response 0.999999999999079 -9.20586147314363e-13 50 0 0 30 5310 WP2637 Structural Pathway of Interleukin 1 (IL-1) 0.999999999999079 -9.20586147314363e-13 50 0 0 30 5310 WP26 Signal Transduction of S1P Receptor 0.99999999999927 -7.30254793081304e-13 26 0 0 30 5310 WP698 Glucuronidation 0.99999999999927 -7.30254793081304e-13 26 0 0 30 5310 WP581 EPO Receptor Signaling 0.99999999999927 -7.30254793081304e-13 26 0 0 30 5310 WP530 Cytokines and Inflammatory Response 0.99999999999927 -7.30254793081304e-13 26 0 0 30 5310 WP2878 PPAR Alpha Pathway 0.99999999999927 -7.30254793081304e-13 26 0 0 30 5310 WP325 Triacylglyceride Synthesis 0.99999999999927 -7.30254793081304e-13 26 0 0 30 5310 WP477 Cytoplasmic Ribosomal Proteins 0.999999999999275 -7.24674215669065e-13 90 0 0 30 5310 WP138 Androgen receptor signaling pathway 0.999999999999275 -7.24674215669065e-13 90 0 0 30 5310 WP688 Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) 0.999999999999324 -6.75695021659269e-13 5 0 0 30 5310 WP2597 Secretion of Hydrochloric Acid in Parietal Cells 0.999999999999324 -6.75695021659269e-13 5 0 0 30 5310 WP2542 Sulindac Metabolic Pathway 0.999999999999324 -6.75695021659269e-13 5 0 0 30 5310 WP311 Synthesis and Degradation of Ketone Bodies 0.999999999999324 -6.75695021659269e-13 5 0 0 30 5310 WP2868 TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer 0.999999999999324 -6.75695021659269e-13 5 0 0 30 5310 WP3596 miR-517 relationship with ARCN1 and USP1 0.999999999999324 -6.75695021659269e-13 5 0 0 30 5310 WP2586 Aryl Hydrocarbon Receptor 0.999999999999483 -5.16931485800434e-13 48 0 0 30 5310 WP2873 Aryl Hydrocarbon Receptor Pathway 0.999999999999483 -5.16931485800434e-13 48 0 0 30 5310 WP2333 Trans-sulfuration pathway 1.00000000000012 1.16685300625653e-13 10 0 0 30 5310 WP2874 Liver X Receptor Pathway 1.00000000000012 1.16685300625653e-13 10 0 0 30 5310 WP3656 Interleukin-1 Induced Activation of NF-kappa-B 1.00000000000012 1.16685300625653e-13 10 0 0 30 5310 WP496 Steroid Biosynthesis 1.00000000000012 1.16685300625653e-13 10 0 0 30 5310 WP2113 Type III interferon signaling 1.00000000000012 1.16685300625653e-13 10 0 0 30 5310 WP1531 Vitamin D Metabolism 1.00000000000012 1.16685300625653e-13 10 0 0 30 5310 WP704 Methylation Pathways 1.00000000000012 1.16685300625653e-13 10 0 0 30 5310 WP422 MAPK Cascade 1.00000000000055 5.51663729318342e-13 29 0 0 30 5310 WP3613 Photodynamic therapy-induced unfolded protein response 1.00000000000055 5.51663729318342e-13 29 0 0 30 5310 WP3893 Development and heterogeneity of the ILC family 1.00000000000095 9.46168284797428e-13 32 0 0 30 5310 WP2875 Constitutive Androstane Receptor Pathway 1.00000000000095 9.46168284797428e-13 32 0 0 30 5310 WP727 Monoamine Transport 1.00000000000095 9.46168284797428e-13 32 0 0 30 5310 WP2525 Trans-sulfuration and one carbon metabolism 1.00000000000095 9.46168284797428e-13 32 0 0 30 5310 WP2828 Bladder Cancer 1.00000000000095 9.46168284797428e-13 32 0 0 30 5310 WP34 Ovarian Infertility Genes 1.00000000000095 9.46168284797428e-13 32 0 0 30 5310 WP3858 Toll-like Receptor Signaling 1.00000000000095 9.46168284797428e-13 32 0 0 30 5310 WP2371 Parkinsons Disease Pathway 1.00000000000103 1.02530711072619e-12 83 0 0 30 5310 WP438 Non-homologous end joining 1.0000000000014 1.40373054531375e-12 7 0 0 30 5310 WP1310 Selenium Micronutrient Network 1.0000000000014 1.40373054531375e-12 7 0 0 30 5310 WP528 Acetylcholine Synthesis 1.0000000000014 1.40373054531375e-12 7 0 0 30 5310 WP1272 Selenium Micronutrient Network 1.0000000000014 1.40373054531375e-12 7 0 0 30 5310 WP3924 Hfe effect on hepcidin production 1.0000000000014 1.40373054531375e-12 7 0 0 30 5310 WP699 Aflatoxin B1 metabolism 1.0000000000014 1.40373054531375e-12 7 0 0 30 5310 WP2805 RNA interference 1.0000000000014 1.40373054531375e-12 7 0 0 30 5310 WP2596 Gastric acid production 1.0000000000014 1.40373054531375e-12 7 0 0 30 5310 WP134 Pentose Phosphate Pathway 1.0000000000014 1.40373054531375e-12 7 0 0 30 5310 WP1995 Effects of Nitric Oxide 1.0000000000014 1.40373054531375e-12 7 0 0 30 5310 WP3595 mir-124 predicted interactions with cell cycle and differentiation 1.0000000000014 1.40373054531375e-12 7 0 0 30 5310 WP678 Arachidonate Epoxygenase / Epoxide Hydrolase 1.0000000000014 1.40373054531375e-12 7 0 0 30 5310 WP410 Diurnally Regulated Genes with Circadian Orthologs 1.00000000000177 1.76800391738347e-12 49 0 0 30 5310 WP534 Glycolysis and Gluconeogenesis 1.00000000000177 1.76800391738347e-12 49 0 0 30 5310 WP2361 Gastric Cancer Network 1 1.00000000000204 2.03967999490615e-12 28 0 0 30 5310 WP2249 Metastatic brain tumor 1.00000000000204 2.03967999490615e-12 28 0 0 30 5310 WP732 Serotonin Receptor 2 and ELK-SRF/GATA4 signaling 1.00000000000219 2.18893439153043e-12 20 0 0 30 5310 WP497 Urea cycle and metabolism of amino groups 1.00000000000219 2.18893439153043e-12 20 0 0 30 5310 WP391 Mitochondrial Gene Expression 1.00000000000219 2.18893439153043e-12 20 0 0 30 5310 WP1742 TP53 Network 1.00000000000219 2.18893439153043e-12 20 0 0 30 5310 WP1422 Sphingolipid Metabolism 1.00000000000219 2.18893439153043e-12 20 0 0 30 5310 WP516 Hypertrophy Model 1.00000000000219 2.18893439153043e-12 20 0 0 30 5310 WP2267 Synaptic Vesicle Pathway 1.00000000000236 2.36316764170721e-12 52 0 0 30 5310 WP2035 Follicle Stimulating Hormone (FSH) signaling pathway 1.00000000000239 2.39311755653257e-12 27 0 0 30 5310 WP3845 Canonical and Non-canonical Notch signaling 1.00000000000239 2.39311755653257e-12 27 0 0 30 5310 WP3925 Amino Acid metabolism 1.00000000000309 3.08909827244791e-12 91 0 0 30 5310 WP2328 Allograft Rejection 1.00000000000337 3.365477210686e-12 80 0 0 30 5310 WP3286 Copper homeostasis 1.00000000000356 3.55941780963391e-12 54 0 0 30 5310 WP623 Oxidative phosphorylation 1.00000000000356 3.55941780963391e-12 54 0 0 30 5310 WP2338 miRNA Biogenesis 1.00000000000384 3.83677969452972e-12 8 0 0 30 5310 WP1589 Folate-Alcohol and Cancer Pathway 1.00000000000384 3.83677969452972e-12 8 0 0 30 5310 WP3655 Hypothetical Craniofacial Development Pathway 1.00000000000384 3.83677969452972e-12 8 0 0 30 5310 WP2276 Glial Cell Differentiation 1.00000000000384 3.83677969452972e-12 8 0 0 30 5310 WP3407 FTO Obesity Variant Mechanism 1.00000000000384 3.83677969452972e-12 8 0 0 30 5310 WP237 Glucocorticoid & Mineralcorticoid Metabolism 1.00000000000384 3.83677969452972e-12 8 0 0 30 5310 WP3635 Insulin signalling in human adipocytes (diabetic condition) 1.00000000000384 3.83677969452972e-12 8 0 0 30 5310 WP1604 Codeine and Morphine Metabolism 1.00000000000384 3.83677969452972e-12 8 0 0 30 5310 WP3634 Insulin signalling in human adipocytes (normal condition) 1.00000000000384 3.83677969452972e-12 8 0 0 30 5310 WP136 Phase I biotransformations, non P450 1.00000000000384 3.83677969452972e-12 8 0 0 30 5310 WP2485 NAD Biosynthesis II (from tryptophan) 1.00000000000384 3.83677969452972e-12 8 0 0 30 5310 WP108 Selenium metabolism/Selenoproteins 1.00000000000402 4.02209342220683e-12 1 0 0 30 5310 WP3191 TSLP Signaling Pathway 1.00000000000402 4.02209342220683e-12 1 0 0 30 5310 WP3627 Gut-Liver Indole Metabolism 1.00000000000402 4.02209342220683e-12 1 0 0 30 5310 WP1 Statin Pathway 1.00000000000402 4.02209342220683e-12 1 0 0 30 5310 WP2190 One carbon donor 1.00000000000402 4.02209342220683e-12 1 0 0 30 5310 WP661 Glucose Homeostasis 1.00000000000402 4.02209342220683e-12 1 0 0 30 5310 WP188 Focal Adhesion 1.00000000000402 4.02209342220683e-12 1 0 0 30 5310 WP2536 Colchicine Metabolic Pathway 1.00000000000402 4.02209342220683e-12 1 0 0 30 5310 WP28 Selenium Metabolism and Selenoproteins 1.0000000000042 4.2024987321164e-12 46 0 0 30 5310 WP465 Tryptophan metabolism 1.0000000000042 4.2024987321164e-12 46 0 0 30 5310 WP1971 Integrated Cancer Pathway 1.0000000000042 4.2024987321164e-12 46 0 0 30 5310 WP1591 Heart Development 1.0000000000042 4.2024987321164e-12 46 0 0 30 5310 WP3878 ATM Signaling Network in Development and Disease 1.0000000000042 4.2024987321164e-12 46 0 0 30 5310 WP268 Notch Signaling Pathway 1.0000000000042 4.2024987321164e-12 46 0 0 30 5310 WP2112 IL17 signaling pathway 1.00000000000433 4.32845996571648e-12 31 0 0 30 5310 WP408 Oxidative Stress 1.00000000000433 4.32845996571648e-12 31 0 0 30 5310 WP3850 Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling 1.00000000000433 4.32845996571648e-12 31 0 0 30 5310 WP2366 Butyrate-induced histone acetylation 1.00000000000435 4.35011887758375e-12 2 0 0 30 5310 WP2866 mir34a and TGIF2 in osteoclastogenesis 1.00000000000435 4.35011887758375e-12 2 0 0 30 5310 WP2646 Lidocaine metabolism 1.00000000000435 4.35011887758375e-12 2 0 0 30 5310 WP1273 Folic Acid Network 1.00000000000435 4.35011887758375e-12 2 0 0 30 5310 WP2943 Hypoxia-mediated EMT and Stemness 1.00000000000435 4.35011887758375e-12 2 0 0 30 5310 WP2816 Felbamate Metabolism 1.00000000000435 4.35011887758375e-12 2 0 0 30 5310 WP1311 Folic Acid Network 1.00000000000435 4.35011887758375e-12 2 0 0 30 5310 WP1438 Influenza A virus infection 1.00000000000435 4.35011887758375e-12 2 0 0 30 5310 WP2901 Gonadotropin-releasing hormone (GnRH) signaling 1.00000000000435 4.35011887758375e-12 2 0 0 30 5310 WP3651 Pathways Affected in Adenoid Cystic Carcinoma 1.00000000000438 4.37838607019108e-12 66 0 0 30 5310 WP183 Proteasome Degradation 1.00000000000438 4.37838607019108e-12 66 0 0 30 5310 WP363 Wnt Signaling Pathway Netpath 1.00000000000443 4.4292043948327e-12 53 0 0 30 5310 WP2406 Cardiac Progenitor Differentiation 1.00000000000443 4.4292043948327e-12 53 0 0 30 5310 WP107 Translation Factors 1.00000000000443 4.4292043948327e-12 53 0 0 30 5310 WP400 p38 MAPK Signaling Pathway 1.00000000000461 4.61342213386278e-12 34 0 0 30 5310 WP1601 Fluoropyrimidine Activity 1.00000000000461 4.61342213386278e-12 34 0 0 30 5310 WP143 Fatty Acid Beta Oxidation 1.00000000000461 4.61342213386278e-12 34 0 0 30 5310 WP1941 Peroxisomal beta-oxidation of tetracosanoyl-CoA 1.00000000000472 4.71961053703438e-12 4 0 0 30 5310 WP897 Androgen receptor signaling pathway 1.00000000000472 4.71961053703438e-12 4 0 0 30 5310 WP2889 Oxytocin signaling 1.00000000000472 4.71961053703438e-12 4 0 0 30 5310 WP2491 Diclofenac Metabolic Pathway 1.00000000000472 4.71961053703438e-12 4 0 0 30 5310 WP3633 Caffeine and Theobromine metabolism 1.00000000000472 4.71961053703438e-12 4 0 0 30 5310 WP1603 Nicotine Activity on Chromaffin Cells 1.00000000000472 4.71961053703438e-12 4 0 0 30 5310 WP733 Serotonin Receptor 2 and STAT3 Signaling 1.00000000000472 4.71961053703438e-12 4 0 0 30 5310 WP1133 Androgen receptor signaling pathway 1.00000000000472 4.71961053703438e-12 4 0 0 30 5310 WP690 Polyol Pathway 1.00000000000472 4.71961053703438e-12 4 0 0 30 5310 WP521 Amino acid conjugation of benzoic acid 1.00000000000472 4.71961053703438e-12 4 0 0 30 5310 WP2253 Pilocytic astrocytoma 1.00000000000472 4.71961053703438e-12 4 0 0 30 5310 WP3302 eIF5A regulation in response to inhibition of the nuclear export system 1.00000000000472 4.71961053703438e-12 4 0 0 30 5310 WP2533 Glycerophospholipid Biosynthetic Pathway 1.00000000000495 4.95167089755188e-12 21 0 0 30 5310 WP2507 Nanomaterial induced apoptosis 1.00000000000495 4.95167089755188e-12 21 0 0 30 5310 WP1602 Nicotine Activity on Dopaminergic Neurons 1.00000000000495 4.95167089755188e-12 21 0 0 30 5310 WP3670 Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway 1.00000000000495 4.95167089755188e-12 21 0 0 30 5310 WP691 Tamoxifen metabolism 1.00000000000495 4.95167089755188e-12 21 0 0 30 5310 WP3617 Photodynamic therapy-induced NF-kB survival signaling 1.00000000000496 4.9633554831391e-12 35 0 0 30 5310 WP299 Nuclear Receptors in Lipid Metabolism and Toxicity 1.00000000000496 4.9633554831391e-12 35 0 0 30 5310 WP3851 TLR4 Signaling and Tolerance 1.000000000005 4.9974577950397e-12 30 0 0 30 5310 WP3844 PI3K-AKT-mTOR signaling pathway and therapeutic opportunities 1.000000000005 4.9974577950397e-12 30 0 0 30 5310 WP2855 Dopaminergic Neurogenesis 1.000000000005 4.9974577950397e-12 30 0 0 30 5310 WP129 Matrix Metalloproteinases 1.000000000005 4.9974577950397e-12 30 0 0 30 5310 WP241 One Carbon Metabolism 1.000000000005 4.9974577950397e-12 30 0 0 30 5310 WP2118 Arrhythmogenic Right Ventricular Cardiomyopathy 1.00000000000504 5.03511616532513e-12 76 0 0 30 5310 WP3624 Lung fibrosis 1.00000000000523 5.22908687328089e-12 63 0 0 30 5310 WP43 Oxidation by Cytochrome P450 1.00000000000523 5.22908687328089e-12 63 0 0 30 5310 WP58 Monoamine GPCRs 1.00000000000577 5.76634424315793e-12 33 0 0 30 5310 WP2197 Endothelin Pathways 1.00000000000577 5.76634424315793e-12 33 0 0 30 5310 WP2363 Gastric Cancer Network 2 1.00000000000577 5.76634424315793e-12 33 0 0 30 5310 WP453 Inflammatory Response Pathway 1.00000000000577 5.76634424315793e-12 33 0 0 30 5310 WP117 GPCRs, Other 1.00000000000585 5.85370412279274e-12 95 0 0 30 5310 WP3645 NAD+ biosynthetic pathways 1.00000000000589 5.89436785094077e-12 22 0 0 30 5310 WP272 Blood Clotting Cascade 1.00000000000589 5.89436785094077e-12 22 0 0 30 5310 WP3872 Regulation of Apoptosis by Parathyroid Hormone-related Protein 1.00000000000589 5.89436785094077e-12 22 0 0 30 5310 WP3599 Transcription factor regulation in adipogenesis 1.00000000000589 5.89436785094077e-12 22 0 0 30 5310 WP3657 Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex 1.00000000000589 5.89436785094077e-12 22 0 0 30 5310 WP1424 Globo Sphingolipid Metabolism 1.00000000000589 5.89436785094077e-12 22 0 0 30 5310 WP545 Complement Activation 1.00000000000589 5.89436785094077e-12 22 0 0 30 5310 WP357 Fatty Acid Biosynthesis 1.00000000000589 5.89436785094077e-12 22 0 0 30 5310 WP100 Glutathione metabolism 1.00000000000589 5.89436785094077e-12 22 0 0 30 5310 WP1982 Sterol Regulatory Element-Binding Proteins (SREBP) signalling 1.00000000000598 5.98075409210265e-12 73 0 0 30 5310 WP466 DNA Replication 1.00000000000617 6.17134245031358e-12 42 0 0 30 5310 WP2036 TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway 1.00000000000617 6.17134245031358e-12 42 0 0 30 5310 WP405 Eukaryotic Transcription Initiation 1.00000000000617 6.17134245031358e-12 42 0 0 30 5310 WP49 IL-2 Signaling Pathway 1.00000000000617 6.17134245031358e-12 42 0 0 30 5310 WP2636 Common Pathways Underlying Drug Addiction 1.00000000000617 6.17134245031358e-12 42 0 0 30 5310 WP2911 miRNA targets in ECM and membrane receptors 1.00000000000634 6.342276951212e-12 43 0 0 30 5310 WP474 Endochondral Ossification 1.00000000000646 6.45808322472939e-12 65 0 0 30 5310 WP558 Complement and Coagulation Cascades 1.00000000000659 6.59280077059246e-12 60 0 0 30 5310 WP3527 Preimplantation Embryo 1.00000000000659 6.59280077059246e-12 60 0 0 30 5310 WP1559 TFs Regulate miRNAs related to cardiac hypertrophy 1.00000000000731 7.31283472488195e-12 12 0 0 30 5310 WP2290 RalA downstream regulated genes 1.00000000000731 7.31283472488195e-12 12 0 0 30 5310 WP3849 MAPK and NFkB Signalling Pathways Inhibited by Yersinia YopJ 1.00000000000731 7.31283472488195e-12 12 0 0 30 5310 WP106 Alanine and aspartate metabolism 1.00000000000731 7.31283472488195e-12 12 0 0 30 5310 WP1425 Bone Morphogenic Protein (BMP) Signalling and Regulation 1.00000000000731 7.31283472488195e-12 12 0 0 30 5310 WP3301 MFAP5-mediated ovarian cancer cell motility and invasiveness 1.00000000000731 7.31283472488195e-12 12 0 0 30 5310 WP2007 Iron metabolism in placenta 1.00000000000731 7.31283472488195e-12 12 0 0 30 5310 WP3879 4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression 1.00000000000759 7.59256032102788e-12 18 0 0 30 5310 WP692 Sulfation Biotransformation Reaction 1.00000000000759 7.59256032102788e-12 18 0 0 30 5310 WP3859 TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition 1.00000000000759 7.59256032102788e-12 18 0 0 30 5310 WP3664 Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds 1.00000000000759 7.59256032102788e-12 18 0 0 30 5310 WP3413 NOTCH1 regulation of human endothelial cell calcification 1.00000000000759 7.59256032102788e-12 18 0 0 30 5310 WP411 mRNA Processing 1.00000000000772 7.72227027769292e-12 132 0 0 30 5310 WP3915 Angiopoietin Like Protein 8 Regulatory Pathway 1.00000000000772 7.72227027769292e-12 132 0 0 30 5310 WP1946 Cori Cycle 1.00000000000867 8.67040161323067e-12 16 0 0 30 5310 WP47 Hedgehog Signaling Pathway 1.00000000000867 8.67040161323067e-12 16 0 0 30 5310 WP12 Osteoclast Signaling 1.00000000000867 8.67040161323067e-12 16 0 0 30 5310 WP501 GPCRs, Class C Metabotropic glutamate, pheromone 1.00000000000867 8.67040161323067e-12 16 0 0 30 5310 WP2453 TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) 1.00000000000867 8.67040161323067e-12 16 0 0 30 5310 WP53 ID signaling pathway 1.00000000000867 8.67040161323067e-12 16 0 0 30 5310 WP550 Biogenic Amine Synthesis 1.00000000000867 8.67040161323067e-12 16 0 0 30 5310 WP2291 Deregulation of Rab and Rab Effector Genes in Bladder Cancer 1.00000000000867 8.67040161323067e-12 16 0 0 30 5310 WP554 ACE Inhibitor Pathway 1.00000000000868 8.67544974734573e-12 17 0 0 30 5310 WP3874 Canonical and Non-Canonical TGF-B signaling 1.00000000000868 8.67544974734573e-12 17 0 0 30 5310 WP2289 Drug Induction of Bile Acid Pathway 1.00000000000868 8.67544974734573e-12 17 0 0 30 5310 WP78 TCA Cycle 1.00000000000868 8.67544974734573e-12 17 0 0 30 5310 WP368 Mitochondrial LC-Fatty Acid Beta-Oxidation 1.00000000000868 8.67544974734573e-12 17 0 0 30 5310 WP2916 Interactome of polycomb repressive complex 2 (PRC2) 1.00000000000868 8.67544974734573e-12 17 0 0 30 5310 WP3678 Amplification and Expansion of Oncogenic Pathways as Metastatic Traits 1.00000000000868 8.67544974734573e-12 17 0 0 30 5310 WP2884 NRF2 pathway 1.00000000000891 8.90691922322476e-12 143 0 0 30 5310 WP231 TNF alpha Signaling Pathway 1.00000000000911 9.10825848309419e-12 94 0 0 30 5310 WP1772 Apoptosis Modulation and Signaling 1.00000000000911 9.10825848309419e-12 94 0 0 30 5310 WP3865 RIG-I-like Receptor Signaling 1.00000000000914 9.14098322036526e-12 61 0 0 30 5310 WP111 Electron Transport Chain 1.00000000000916 9.15864279281686e-12 92 0 0 30 5310 WP2377 Integrated Pancreatic Cancer Pathway 1.00000000000991 9.91203232159164e-12 197 0 0 30 5310 WP1544 MicroRNAs in cardiomyocyte hypertrophy 1.00000000001001 1.00127105897499e-11 102 0 0 30 5310 WP2064 Neural Crest Differentiation 1.00000000001001 1.00127105897499e-11 102 0 0 30 5310 WP2446 Retinoblastoma (RB) in Cancer 1.00000000001003 1.00310584812229e-11 88 0 0 30 5310 WP712 Estrogen signaling pathway 1.00000000001019 1.01872815300309e-11 23 0 0 30 5310 WP3612 Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling 1.00000000001019 1.01872815300309e-11 23 0 0 30 5310 WP2032 Human Thyroid Stimulating Hormone (TSH) signaling pathway 1.00000000001026 1.02597739210933e-11 68 0 0 30 5310 WP3303 Rac1/Pak1/p38/MMP-2 pathway 1.00000000001026 1.02597739210933e-11 68 0 0 30 5310 WP3680 Association Between Physico-Chemical Features and Toxicity Associated Pathways 1.00000000001026 1.02597739210933e-11 68 0 0 30 5310 WP1403 AMP-activated Protein Kinase (AMPK) Signaling 1.00000000001026 1.02597739210933e-11 68 0 0 30 5310 WP45 G1 to S cell cycle control 1.00000000001026 1.02597739210933e-11 68 0 0 30 5310 WP24 Peptide GPCRs 1.00000000001032 1.03190051638043e-11 74 0 0 30 5310 WP2865 IL1 and megakaryocytes in obesity 1.00000000001035 1.03500185884318e-11 25 0 0 30 5310 WP205 IL-7 Signaling Pathway 1.00000000001035 1.03500185884318e-11 25 0 0 30 5310 WP2895 Differentiation of white and brown adipocyte 1.00000000001035 1.03500185884318e-11 25 0 0 30 5310 WP3668 Hypothesized Pathways in Pathogenesis of Cardiovascular Disease 1.00000000001035 1.03500185884318e-11 25 0 0 30 5310 WP1528 Physiological and Pathological Hypertrophy of the Heart 1.00000000001035 1.03500185884318e-11 25 0 0 30 5310 WP2436 Dopamine metabolism 1.00000000001059 1.05866189430808e-11 14 0 0 30 5310 WP229 Irinotecan Pathway 1.00000000001059 1.05866189430808e-11 14 0 0 30 5310 WP322 Osteoblast Signaling 1.00000000001059 1.05866189430808e-11 14 0 0 30 5310 WP3853 ERK Pathway in Huntington's Disease 1.00000000001059 1.05866189430808e-11 14 0 0 30 5310 WP1530 miRNA Regulation of DNA Damage Response 1.00000000001065 1.06459738977349e-11 93 0 0 30 5310 WP2431 Spinal Cord Injury 1.00000000001068 1.06836941528939e-11 119 0 0 30 5310 WP3529 Zinc homeostasis 1.00000000001092 1.09217476179033e-11 37 0 0 30 5310 WP3414 Initiation of transcription and translation elongation at the HIV-1 LTR 1.00000000001092 1.09217476179033e-11 37 0 0 30 5310 WP1471 Target Of Rapamycin (TOR) Signaling 1.00000000001092 1.09217476179033e-11 37 0 0 30 5310 WP1433 Nucleotide-binding Oligomerization Domain (NOD) pathway 1.00000000001157 1.15697621739001e-11 41 0 0 30 5310 WP3584 MECP2 and Associated Rett Syndrome 1.00000000001157 1.15746879588342e-11 62 0 0 30 5310 WP2513 Nanoparticle triggered regulated necrosis 1.00000000001209 1.20875244285339e-11 11 0 0 30 5310 WP2854 Gene regulatory network modelling somitogenesis 1.00000000001209 1.20875244285339e-11 11 0 0 30 5310 WP1455 Serotonin Transporter Activity 1.00000000001209 1.20875244285339e-11 11 0 0 30 5310 WP2435 Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis 1.00000000001217 1.21709804830357e-11 15 0 0 30 5310 WP206 Fatty Acid Omega Oxidation 1.00000000001217 1.21709804830357e-11 15 0 0 30 5310 WP197 Cholesterol Biosynthesis 1.00000000001217 1.21709804830357e-11 15 0 0 30 5310 WP3 Transcriptional activation by NRF2 1.00000000001217 1.21709804830357e-11 15 0 0 30 5310 WP702 Metapathway biotransformation 1.00000000001279 1.27945538524414e-11 177 0 0 30 5310 WP170 Nuclear Receptors 1.00000000001417 1.41719388667677e-11 39 0 0 30 5310 WP3611 Photodynamic therapy-induced AP-1 survival signaling. 1.0000000000142 1.41999180561259e-11 51 0 0 30 5310 WP3594 Circadian rythm related genes 1.00000000001455 1.45467783199332e-11 207 0 0 30 5310 WP1984 Integrated Breast Cancer Pathway 1.0000000000147 1.47040266093931e-11 154 0 0 30 5310 WP366 TGF-beta Signaling Pathway 1.000000000015 1.49964902648419e-11 133 0 0 30 5310 WP1981 Thyroxine (Thyroid Hormone) Production 1.00000000001534 1.53407367153833e-11 6 0 0 30 5310 WP1600 Nicotine Metabolism 1.00000000001534 1.53407367153833e-11 6 0 0 30 5310 WP694 Arylamine metabolism 1.00000000001534 1.53407367153833e-11 6 0 0 30 5310 WP3891 Benzene metabolism 1.00000000001534 1.53407367153833e-11 6 0 0 30 5310 WP15 Selenium Micronutrient Network 1.00000000001613 1.6130630854709e-11 87 0 0 30 5310 WP524 G13 Signaling Pathway 1.00000000001666 1.66599275022546e-11 40 0 0 30 5310 WP2516 ATM Signaling Pathway 1.00000000001666 1.66599275022546e-11 40 0 0 30 5310 WP127 IL-5 Signaling Pathway 1.00000000001666 1.66599275022546e-11 40 0 0 30 5310